Hepatitis C update. New answers, new questions.
Currently available tests for infection with the hepatitis C virus detect the presence of antibodies against the virus. The value of these tests is limited, however, because the appearance of antibodies may be delayed and because there is a significant rate of false-positive results. Supplementary tests now being developed should greatly facilitate diagnosis of hepatitis C. Patients with chronic liver disease due to the hepatitis C virus can be treated with interferon alfa-2b (Intron A). This treatment should also be considered for patients with markedly elevated transaminase levels, evidence of significant histologic injury, or symptoms referable to the liver.